Literature DB >> 26709382

An exploratory study of therapeutic misconception among incarcerated clinical trial participants.

Paul P Christopher1, Michael D Stein1, Sandra A Springer2, Josiah D Rich1, Jennifer E Johnson1, Charles W Lidz3.   

Abstract

BACKGROUND: Therapeutic misconception, the misunderstanding of differences between research and clinical care, is widely prevalent among non-incarcerated trial participants. Yet little attention has been paid to its presence among individuals who participate in research while incarcerated.
METHODS: This study examined the extent to which seventy-two incarcerated individuals may experience therapeutic misconception about their participation in one of six clinical trials, and its correlation with participant characteristics and potential influences on research participation.
RESULTS: On average, participants endorsed 70% of items suggestive of therapeutic misconception. The tendency toward therapeutic misconception was significantly higher among: African Americans and Latinos compared to Whites; older and less educated participants; enrollment in a substance abuse-related trial; and correlated with a belief that the trial was the only way to obtain needed treatment.
CONCLUSIONS: Therapeutic misconception may be particularly high among select incarcerated individuals and is associated with a perceived lack of treatment options. Further examination of therapeutic misconception among incarcerated research participants is needed.

Entities:  

Keywords:  incarceration; informed consent; prisoners; therapeutic misconception; vulnerable populations

Year:  2015        PMID: 26709382      PMCID: PMC4687735          DOI: 10.1080/23294515.2015.1058303

Source DB:  PubMed          Journal:  AJOB Empir Bioeth        ISSN: 2329-4515


  36 in total

1.  The disease profile of Texas prison inmates.

Authors:  J Baillargeon; S A Black; J Pulvino; K Dunn
Journal:  Ann Epidemiol       Date:  2000-02       Impact factor: 3.797

2.  Distrust, race, and research.

Authors:  Giselle Corbie-Smith; Stephen B Thomas; Diane Marie M St George
Journal:  Arch Intern Med       Date:  2002-11-25

3.  Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Authors:  Jaimie P Meyer; Javier Cepeda; Johnny Wu; Robert L Trestman; Frederick L Altice; Sandra A Springer
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

4.  Sex, drugs, prisons, and HIV.

Authors:  Susan Okie
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

5.  Compensation for incarcerated research participants: diverse state policies suggest a new research agenda.

Authors:  Amy B Smoyer; Kim M Blankenship; Brandis Belt
Journal:  Am J Public Health       Date:  2009-08-20       Impact factor: 9.308

6.  Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community.

Authors:  Sandra A Springer; Edward Pesanti; John Hodges; Thomas Macura; Gheorghe Doros; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2004-05-26       Impact factor: 9.079

7.  Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument.

Authors:  Laura B Dunn; Barton W Palmer; Monique Keehan; Dilip V Jeste; Paul S Appelbaum
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

8.  Therapeutic misconception in research subjects: development and validation of a measure.

Authors:  Paul S Appelbaum; Milena Anatchkova; Karen Albert; Laura B Dunn; Charles W Lidz
Journal:  Clin Trials       Date:  2012-08-31       Impact factor: 2.486

9.  Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception.

Authors:  I S Durand-Zaleski; C Alberti; P Durieux; X Duval; S Gottot; Ph Ravaud; S Gainotti; C Vincent-Genod; D Moreau; P Amiel
Journal:  J Med Ethics       Date:  2008-09       Impact factor: 2.903

10.  An Empirical Ethics Agenda for Psychiatric Research Involving Prisoners.

Authors:  Paul P Christopher; Philip J Candilis; Josiah D Rich; Charles W Lidz
Journal:  AJOB Prim Res       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.